What is the alcoholic liver score (ABIC) and how is it calculated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ABIC Score: A Prognostic Tool for Alcoholic Hepatitis

The ABIC (Age, Bilirubin, INR, Creatinine) score is a validated prognostic model that stratifies patients with alcoholic hepatitis into low, intermediate, and high-risk categories for mortality at 90 days and 1 year.

Calculation Formula

The ABIC score is calculated using the following formula 1:

ABIC = (Age in years × 0.1) + (Serum bilirubin in mg/dL × 0.08) + (Serum creatinine in mg/dL × 0.3) + (INR × 0.8)

Risk Stratification

Using cutoff values of 6.71 and 9.0, the ABIC model divides patients into three distinct prognostic categories 1, 2:

  • Low risk: ABIC < 6.71 → 100% survival at 90 days
  • Intermediate risk: ABIC 6.71-9.0 → 70% survival at 90 days
  • High risk: ABIC > 9.0 → 25% survival at 90 days

The score maintains its predictive accuracy for 1-year mortality as well 1, 2.

Clinical Application

ABIC score category C (high risk) predicts high 28- and 90-day mortality rates 3. The 2017 AGA guidelines specifically recommend using ABIC as one of several validated tools for severity assessment in alcoholic hepatitis 3.

Patients with intermediate risk of death may benefit from corticosteroid or pentoxifylline therapy 1. The ABIC score provides three-tiered stratification, which offers more granular prognostic information compared to binary classification systems 4.

Comparative Performance

The ABIC score performs comparably to other established prognostic models including the modified Maddrey discriminant function (mDF), MELD score, and Glasgow Alcoholic Hepatitis Score (GAHS) for predicting short-term mortality 1. All these models are good predictors of short-term mortality but poor predictors of long-term mortality 1.

The main advantage of ABIC is its three-tiered risk stratification, allowing more nuanced clinical decision-making 4. However, one limitation is that it was originally developed and validated primarily in Spanish populations, and the optimal threshold for initiating corticosteroids remains uncertain 4.

Clinical Context

The ABIC score should be used as part of comprehensive severity assessment in alcoholic hepatitis 3. It is most useful for prognostic stratification at admission (a "static" pretreatment model) rather than for monitoring treatment response 1. For treatment response assessment, dynamic models like the Lille score are more appropriate 1.

Important caveat: While ABIC effectively predicts short-term mortality, abstinence from alcohol remains the primary determinant of long-term prognosis in alcoholic liver disease 5.

Related Questions

What is the appropriate management for a 44-year-old male with alcohol use disorder, triglyceride level increased from 428 mg/dL to 1,381 mg/dL while on fenofibrate 48 mg, and mildly elevated AST (65 U/L) and ALT (116 U/L)?
What is the appropriate management for a 46‑year‑old male with alcoholic use disorder, cirrhosis, prior variceal banding, presenting with hepatic encephalopathy, hemoglobin 7.8 g/dL (down from 8.3 g/dL), blood urea nitrogen 52 mg/dL (up from 51 mg/dL), and a CO₂ of 17 mmHg?
In a 49-year-old who binge‑drank alcohol for three days and now presents with epigastric burning pain and generalized pruritus, what is the likely diagnosis and recommended treatment?
In a 52-year-old patient with alcoholic cirrhosis and hepatic encephalopathy who had a 10‑L paracentesis five days ago and now presents in a catatonic state with minimal responsiveness, what immediate supportive measures and specific treatments should be initiated while awaiting laboratory results?
In a 25-year-old patient with an isolated ALT (alanine aminotransferase) of 100 U/L on routine examination, which is the least likely cause: hepatitis B, hepatitis C, alcoholic steatohepatitis, non-alcoholic steatohepatitis, or primary biliary cholangitis?
When should cefotaxime be preferred over ceftriaxone, and what are the dosing regimens and considerations for each drug?
In patients with advanced non‑small cell lung cancer (NSCLC) or colorectal cancer, should I test for KEAP1 mutations, and how does a pathogenic KEAP1 alteration affect prognosis and treatment decisions?
What does it mean when a variable is statistically significant in univariate analysis but not in multivariate analysis?
Can Leqvio (inclisiran) cause muscle pain?
What is the most common adverse effect of monoclonal antibody medications?
Is elevated hemoglobin (polycythemia) indicative of chronic hypoxia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.